Governance
Investors
About us
Profile
Management
Board
Scientific Advisory Board
Our Science
Strategy
Enabling Technologies
Product Classes
Pipeline
Pipeline
Nidlegy
TM
Fibromun
Darleukin
Dodekin
Dekavil
Onco IX
OncoFAP Radio Conjugates
Tripokin
Press Releases & Media
Press Releases
Events
Philogen in the news
Media Library
Work with us
Careers
Partnering
About us
Profile
Management
Board
Scientific Advisory Board
Our Science
Strategy
Enabling Technologies
Product Classes
Pipeline
Pipeline
Nidlegy
TM
Fibromun
Darleukin
Dekavil
Dodekin
Onco IX
OncoFAP Radio Conjugates
Tripokin
Press Releases & Media
Press Releases
Events
Media Library
Philogen in the news
Work with us
Careers
Partnering
Investors
Investor Relations
Shareholding
IPO
Press Releases
Financial Statements
Financial Calendar
Internal Dealing
Buyback
Analyst Coverage
Webinars
IR Contacts
Governance
Board of Directors
Board of Statutory Auditors
Documents & Procedures
Shareholders’ Meetings
Codice etico e Modello 231
Sustainability (ESG)
News & Events
2022
,
Investors
,
Press Releases
21 novembre 2022 – Aggiornamento sul programma di acquisto di azioni proprie
Nov 21, 2022
More details
Last News & Events
Mar
2022
21
21 marzo 2022 – Aggiornamento sul programma di acquisto di azioni proprie
Mar
2022
15
Notice of Full Year 2021 Results
« Previous
1
…
72
73
74
75
76
…
117
Next »
